Review article: Medical treatment of severe ulcerative colitis

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 17, Issue 2, 2003, Pages 7-10

  Rizzello, F ^a   Gionchetti, P ^a   Venturi, A ^a   Campieri, M ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; ANTIBIOTIC AGENT; AZATHIOPRINE; C REACTIVE PROTEIN; CIPROFLOXACIN; CORTICOSTEROID; CORTICOTROPIN; CYCLOSPORIN; HYDROCORTISONE; INFLIXIMAB; MERCAPTOPURINE; METHYLPREDNISOLONE; METRONIDAZOLE; PREDNISOLONE; PREDNISOLONE 21 PHOSPHATE; RIFAXIMIN; TOBRAMYCIN; VANCOMYCIN;

ADRENAL CORTEX DISEASE; ANTIBIOTIC THERAPY; CLINICAL FEATURE; CLINICAL TRIAL; COLON RESECTION; CONFERENCE PAPER; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG INFUSION; DRUG SCREENING; EARLY DIAGNOSIS; FECES ANALYSIS; FEVER; GAS; HUMAN; HYPERTENSION; HYPOALBUMINEMIA; INFECTION; INTESTINE; INTESTINE DISTENSION; LABORATORY TEST; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; NAUSEA; NECROSIS; NEPHROTOXICITY; OUTCOMES RESEARCH; PARAMETER; PARESTHESIA; PATIENT MONITORING; PATIENT REFERRAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RADIODIAGNOSIS; REST; SEIZURE; SURGEON; TREATMENT OUTCOME; ULCERATIVE COLITIS; VOMITING;

ADRENAL CORTEX HORMONES; ANTI-BACTERIAL AGENTS; ANTIBODIES, MONOCLONAL; COLITIS, ULCERATIVE; CYCLOSPORINE; GASTROINTESTINAL AGENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; TREATMENT OUTCOME;

EID: 0038574374     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Truelove SC, Witts LJ. Cortisone in ulcerative colitis: preliminary report on a therapeutic trial. Br Med J 1954; 2: 375-8.
2. Truelove SC, Jewell DP. Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet 1974; 1: 1067-70.
3. Baron JH, Conell AM, Lennard-Jones JE. Variation between observers in describing mucosal appearance in proctocolitis. Br Med J 1964; 1: 89-92.
4. Carbonnel F, Lavergne A, Lèmann M, et al. Colonoscopy of acute colitis: a safe and reliable tool for assessment of severity. Dig Dis Sci 1994; 39: 1550-7.
5. Travis SPL, Farrant JM, Ricketts C, et al. Predicting outcome in severe ulcerative colitis. Gut 1996; 38: 905-10.
6. Lennard-Jones JE, Ritchie JK, Hilder W, et al. Assessment of severity in colitis: a preliminary study. Gut 1975; 16: 579-84.
7. Caprilli R, Vernia P, Latella G, et al. Early recognition of toxic megacolon. J Clin Gastroenterol 1987; 9: 160-4.
8. Chew CN, Nolan DJ, Jewell DP. Small bowel gas in severe ulcerative colitis. Gut 1991; 32: 1535-7.
9. Edward FC, Truelove SC. The course and prognosis of ulcerative colitis. Gut 1963; 4: 299-315.
10. Jarnerot G, Rolny P, Sandberg-Gertzen H. Intensive intravenous treatment of ulcerative colitis. Gastroenterology 1985; 89: 1005-13.
11. Kaplan HP, Portnoy HJ, Binder HJ, et al. A controlled evaluation of intravenous adrenocorticotropin hormone and hydrocortisone in the treatment of acute colitis. Gastroenterol 1975; 69: 91-5.
12. Dickinson RJ, Ashton MG, Axon ATR, et al. Controlled trial of intravenous hyperalimentation and total bowel rest as an adjunct to the routine therapy of acute colitis. Gastroenterol 1980; 79: 1199-204.
13. Chapman RW, Selby WS, Jewell DP. Controlled trial of intravenous metronidazolo as an adjunt to corticosteroids in severe ulcerative colitis. Gut 1986; 27: 1210-2.
14. Mantzaris GJ, Petraki K, Archavlis E, et al. A prospective randomized controlled trial of intravenous cip as an adjunct to corticosteroids in acute, severe ulcerative colitis. Scand J Gastroenterol 2001; 36: 971-4.
15. Dickinson RJ, O'Connor HJ, Pinder I, et al. Double-blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbation of idiopathic colitis. Gut 1985; 26: 1380-4.
16. Burke DA, Axon ATR, Clayden SA, et al. The efficacy of tobramycin in the treatment of ulcerative colitis. Aliment Pharmacol Ther 1990; 4: 123-9.
17. Gionchetti P, Rizzello F, Ferrieri A, et al. Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid treatment: a double-blind, placebo-controlled trial. Dig Dis Sci 1999; 44(6): 1220-1.
18. Lightiger S, Present D, Kornbluth A, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994; 330: 1841-5.
19. Actis GC, Ottobrelli A, Pera A, et al. Continously infused cyclosporine at low dose is sufficient to avoid emergency colectomy in acute attacks of ulcerative colitis without the need for high-dose steroids. J Clin Gastroenterol 1993; 17(1): 10-3.
20. Actis GC, Aimo G, Priolo G, et al. Efficacy and efficiency of oral microemulsion cyclosporin versus intravenous and sof gelatin cyclosporine in the treatment of severe steroid-refractory ulcerative colitis: an open retrospective trial. Inflamm Bowel Dis 1998; 4: 276-9.
21. Chey W. Infliximab for patients with refractory ulcerative colitis. Inflamm Bowel Dis 2001; 1: s30-3.
22. Sands ES, Tremaine WJ, Sandborne WJ, et al. Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study. Inflamm Bowel Dis 2001; 7: 83-8.
23. Kohn A, Prantera C, Pera A, et al. Anti-tumor necrosis factor alpha (infliximab) in the treatment of severe ulcerative colitis: result of an open study on 13 patients. Dig Liv Dis 2002; 34: 626-30.